BMC Biotechnology (Sep 2002)

Construction and high cytoplasmic expression of a tumoricidal single-chain antibody against hepatocellular carcinoma

  • Imanaka Tadayuki,
  • Tsukio Manae,
  • Tungpradabkul Sumalee,
  • Sandee Duanpen,
  • Takagi Masahiro

DOI
https://doi.org/10.1186/1472-6750-2-16
Journal volume & issue
Vol. 2, no. 1
p. 16

Abstract

Read online

Abstract Background Hep27 monoclonal (Hep27 Mab) is an antibody against hepatocellular carcinoma. Hep27 Mab itself can inhibit the growth of a hepatocellular carcinoma cell line (HCC-S102). We attempted to produce a single-chain fragment (scFv), a small fragment containing an antigen-binding site of Hep27 Mab, by using DNA-recombinant techniques. Results The sequences encoding the variable regions of heavy (VH) and light (VL) chains of a murine Hep27 Mab were linked together by a linker peptide (Gly4Ser)3 and tagged with a hexa-histidine at the C-terminal; the resultant DNA construct was expressed in E. coli as an insoluble protein. The denatured scFv was refolded and purified by immobilized metal ion affinity chromatography (12 mg/l with a molecular weight of 27 kDa). Hep27scFv exhibited a tumoricidal activity against the HCC-S102 cell as its parental antibody (Hep27 Mab). Conclusion This scFv may be a potential candidate for a targeting agent in HCC immunodiagnosis or immunotherapy.

Keywords